Global Coronary Atherectomy Devices Market Growth, Share, Size, Trends and Forecast (2025 - 2031)
By Product;
Directional Atherectomy Devices, Orbital Atherectomy Devices, Photo-Ablative Atherectomy Devices, Rotational Atherectomy Devices, and Others.By Application;
Peripheral Vascular, Cardiovascular, and Neurovascular.By End User;
Hospitals And Surgical Centers, Ambulatory Care Centers, and Research Laboratories, And Academic Institutes.By Geography;
North America, Europe, Asia Pacific, Middle East and Africa and Latin America - Report Timeline (2021 - 2031).Introduction
Global Coronary Atherectomy Devices Market (USD Million), 2021 - 2031
In the year 2024, the Global Coronary Atherectomy Devices Market was valued at USD 233.59 million. The size of this market is expected to increase to USD 476.16 million by the year 2031, while growing at a Compounded Annual Growth Rate (CAGR) of 10.7%.
The global coronary atherectomy devices market is a critical component of the cardiovascular medical device industry, driven by the increasing prevalence of coronary artery disease (CAD) and advancements in minimally invasive surgical technologies. Coronary artery disease is one of the leading causes of death worldwide, with millions of people affected by blocked or narrowed coronary arteries. Atherectomy devices, which are used to remove atherosclerotic plaque from the arteries, play a crucial role in improving blood flow and preventing further complications associated with CAD, including heart attacks and strokes. These devices are used in conjunction with other interventional cardiology procedures, such as angioplasty and stenting, to treat complex lesions that are difficult to address with traditional balloon angioplasty alone. The growing awareness of CAD, along with the rising aging population and an increase in risk factors such as hypertension, diabetes, smoking, and obesity, has led to a surge in demand for effective treatments like coronary atherectomy. As a result, the coronary atherectomy devices market is experiencing substantial growth.
Atherectomy devices can be categorized into several types, including directional atherectomy devices, orbital atherectomy devices, photo-ablation atherectomy devices, rotational atherectomy devices, and others, each catering to specific clinical needs. Directional atherectomy devices are widely used for their ability to remove plaque in a controlled direction, providing a safe and effective way to address coronary blockages. Orbital atherectomy devices use high-speed rotational motion to help break down plaque, particularly in cases of calcified lesions that may be more resistant to other treatments. Photo-ablation atherectomy devices utilize laser technology to vaporize and remove plaque, offering precision in delicate areas. Rotational atherectomy devices are used for high-speed plaque removal, particularly in patients with more hardened or calcified arterial blockages. The advancements in these technologies have significantly improved the ability to treat complex coronary lesions, reduce the risk of restenosis (re-narrowing of the artery), and enhance long-term patient outcomes. As the demand for minimally invasive treatments increases, these devices offer patients an option for safer and less invasive procedures compared to traditional open-heart surgery.
One of the primary drivers of market growth is the rising global prevalence of cardiovascular diseases and the increasing number of coronary artery interventions performed annually. Coronary interventions, including the use of atherectomy devices, are crucial for managing a growing number of patients suffering from CAD, especially as the global population ages. Additionally, advancements in medical technologies have led to more efficient and user-friendly atherectomy devices, which are easier to use and provide better precision in plaque removal. This has further fueled the adoption of atherectomy devices in hospitals, specialty clinics, ambulatory surgical centers, and diagnostic laboratories. Furthermore, these devices play a vital role in addressing complex cases of coronary artery disease, such as those involving heavily calcified lesions or challenging arterial anatomies, where traditional balloon angioplasty or stenting may be less effective.
Another factor contributing to the market’s growth is the shift toward minimally invasive procedures. Atherectomy procedures offer a less invasive alternative to traditional coronary artery bypass graft (CABG) surgery, leading to shorter recovery times, fewer complications, and reduced hospital stays. This trend is particularly important as healthcare systems worldwide seek to reduce costs while improving patient outcomes. Moreover, the increase in outpatient procedures, especially in ambulatory surgical centers, has enhanced the accessibility of these advanced treatment options. As a result, coronary atherectomy devices are being increasingly used in various healthcare settings, contributing to the overall expansion of the market. In parallel, ongoing research and development efforts continue to enhance the efficacy, safety, and versatility of these devices, ensuring that coronary atherectomy remains a key option in the treatment of coronary artery disease. With the growing demand for effective, minimally invasive treatments and continuous innovation in device technology, the global coronary atherectomy devices market is poised for sustained growth in the coming years.
Global Coronary Atherectomy Devices Market Recent Developments
-
In December 2021, Koninklijke Philips N.V. announced the acquisition of Vesper Medical Inc., a U.S.-based medical technology company specializing in the development of minimally invasive peripheral vascular devices. Through this acquisition, Koninklijke Philips N.V. enhanced its existing portfolio of diagnostic and therapeutic devices by incorporating Vesper Medical Inc.'s cutting-edge venous stent portfolio, specifically designed for the treatment of deep venous disease.
-
In August 2021, Medtronic updated its old medical device HawkOne Directional Atherectomy System which was launched in 2015 to boost its presence in the global market. Food and Drug Administration (FDA) approved the device application update.
Segment Analysis
The Global Coronary Atherectomy Devices Market is segmented by product into directional atherectomy devices, orbital atherectomy devices, photo-ablative atherectomy devices, rotational atherectomy devices, and others. Among these, rotational atherectomy devices hold the largest market share due to their widespread use in treating complex coronary lesions. These devices use a rotating catheter to remove plaque from the arteries, improving blood flow and reducing the risk of heart attacks. Directional atherectomy devices are also widely used for their ability to remove plaque in a controlled direction, often preferred in less complicated cases. As technology advances, orbital and photo-ablative atherectomy devices are gaining traction for their precision in treating various types of arterial blockages, contributing to the growth of their respective segments.
In terms of application, the market is divided into peripheral vascular, cardiovascular, and neurovascular applications. The cardiovascular segment remains the largest, driven by the high prevalence of coronary artery disease (CAD). Atherectomy devices play a crucial role in plaque removal in coronary arteries, significantly improving patient outcomes in CAD treatment. The peripheral vascular segment is also seeing strong growth due to the increasing prevalence of peripheral artery disease (PAD), which often necessitates atherectomy procedures for effective plaque removal and improved blood circulation. Meanwhile, the neurovascular segment, although smaller, is poised for growth with the increasing application of atherectomy in cerebrovascular diseases, such as stroke prevention and cerebral atherosclerosis treatment.
The end-user segment of the market is categorized into hospitals and surgical centers, ambulatory care centers, and research laboratories and academic institutes. Hospitals and surgical centers dominate the market as they perform the majority of coronary and peripheral vascular procedures, where atherectomy devices are crucial for treating arterial blockages. The ambulatory care centers segment is growing rapidly due to the increasing preference for outpatient procedures, as patients seek less invasive treatments for coronary artery disease. Additionally, research laboratories and academic institutes are important drivers of innovation in the atherectomy device market, contributing to new product development and clinical trials, particularly in emerging areas such as neurovascular applications.
Global Coronary Atherectomy Devices Segment Analysis
In this report, the Global Coronary Atherectomy Devices Market has been segmented by Product, Application, End User, and Geography.
Global Coronary Atherectomy Devices Market, Segmentation by Product
The Global Coronary Atherectomy Devices Market has been segmented by Product into Directional Atherectomy Devices, Orbital Atherectomy Devices, Photo-Ablative Atherectomy Devices, Rotational Atherectomy Devices, and Others.
These include Directional Atherectomy Devices, which involve cutting and extracting plaque from arterial walls with precision. Orbital Atherectomy Devices employ rotational mechanisms to ablate calcified plaque, while Photo-Ablative Atherectomy Devices utilize laser energy for plaque vaporization. Rotational Atherectomy Devices utilize high-speed rotating burrs to shave and remove plaque. Additionally, the "Others" category encompasses emerging atherectomy technologies. Each product category offers unique advantages and applications in addressing various plaque compositions and lesion complexities, providing interventional cardiologists with a comprehensive arsenal for coronary artery disease treatment.
This segmentation reflects the diverse landscape of coronary atherectomy devices, highlighting the wide array of options available to healthcare providers for plaque removal and restoration of blood flow in coronary arteries. As cardiovascular disease prevalence continues to rise globally, driven by aging populations and lifestyle factors, demand for these devices is expected to grow, spurring innovation and market expansion in the coming years.
Global Coronary Atherectomy Devices Market, Segmentation by Application
The Global Coronary Atherectomy Devices Market has been segmented by Application into Peripheral Vascular, Cardiovascular, and Neurovascular.
The Global Coronary Atherectomy Devices Market is segmented by application into peripheral vascular, cardiovascular, and neurovascular. The cardiovascular segment holds the largest share, as coronary atherectomy devices are primarily used in the treatment of coronary artery disease (CAD), which is a leading cause of heart attacks worldwide. These devices help remove plaque buildup in the arteries, allowing for improved blood flow and reduced risk of cardiovascular events. As the incidence of CAD continues to rise globally, the demand for coronary atherectomy devices in this segment is expected to remain high.
The peripheral vascular application segment is another key area for coronary atherectomy devices, addressing plaque removal in peripheral arteries, such as those in the legs and arms. Peripheral artery disease (PAD), often caused by the same risk factors as CAD, leads to a narrowing of the peripheral arteries, restricting blood flow and causing severe complications. Atherectomy devices are used to restore patency and improve circulation in these peripheral arteries. The increasing prevalence of PAD, particularly in aging populations and individuals with diabetes or hypertension, is driving the growth of this segment.
Lastly, the neurovascular segment is witnessing gradual growth, with coronary atherectomy devices being applied to treat blockages in the arteries that supply the brain, such as in cases of cerebral atherosclerosis or stroke prevention. Though smaller compared to the cardiovascular and peripheral vascular segments, the neurovascular application is gaining attention due to advancements in technology and the rising incidence of cerebrovascular diseases. The adoption of atherectomy devices in neurovascular procedures is expected to grow as healthcare providers increasingly recognize their potential for improving patient outcomes in treating neurovascular diseases.
Global Coronary Atherectomy Devices Market, Segmentation by End User
The Global Coronary Atherectomy Devices Market has been segmented by End User into Hospitals And Surgical Centers, Ambulatory Care Centers, and Research Laboratories, And Academic Institutes
Hospitals and Surgical Centers constitute a major end user segment, serving as primary facilities for interventional procedures and cardiac interventions. These settings provide comprehensive care for patients with coronary artery disease (CAD) and are equipped with the necessary infrastructure and expertise to perform atherectomy procedures effectively.
Ambulatory Care Centers represent another significant end user segment, offering outpatient services for CAD management, including atherectomy procedures. These centers cater to patients seeking minimally invasive treatments outside of traditional hospital settings, providing convenience and accessibility for a wide range of cardiac interventions.
Research Laboratories and Academic Institutes play a crucial role in advancing atherectomy technology and techniques through research and innovation. These institutions contribute to the development of new devices and procedures, enhancing the efficacy and safety of atherectomy interventions. By segmenting the market based on end users, this approach provides insights into the diverse settings where coronary atherectomy devices are utilized, facilitating strategic planning and targeted marketing efforts to address the specific needs of each segment.
Global Coronary Atherectomy Devices Market, Segmentation by Geography
In this report, the Global Coronary Atherectomy Devices Market has been segmented by Geography into five regions; North America, Europe, Asia Pacific, Middle East and Africa and Latin America.
Global Coronary Atherectomy Devices Market Share (%), by Geographical Region, 2024
North America and Europe are expected to dominate the market, owing to their advanced healthcare systems, high prevalence of coronary artery disease (CAD), and significant investments in medical technology. These regions are also at the forefront of research and development, driving innovation in atherectomy devices and procedures.
Asia Pacific, Middle East and Africa, and Latin America are witnessing rapid market growth due to increasing awareness about cardiovascular health, improving healthcare infrastructure, and rising prevalence of CAD risk factors. As these regions prioritize healthcare accessibility and affordability, they present promising opportunities for market expansion and investment in coronary atherectomy devices. This geographical segmentation provides valuable insights into regional variations in market size, growth trends, and regulatory landscapes, facilitating informed decision-making and strategic planning in the global coronary atherectomy devices market.
Market Trends
This report provides an in depth analysis of various factors that impact the dynamics of Global Coronary Atherectomy Devices Market. These factors include; Market Drivers, Restraints and Opportunities Analysis.
Drivers, Restraints and Opportunity Analysis
Drivers :
- Rising Prevalence of Cardiovascular Diseases (CVDs)
- Technological Advancements
-
Favorable Reimbursement Scenario - The Global Coronary Atherectomy Devices Market is experiencing growth attributed to a favorable reimbursement scenario, particularly in regions such as North America and Europe. These regions boast well-established healthcare systems with robust reimbursement policies for medical procedures and devices. Reimbursement mechanisms, such as government-funded healthcare programs and private insurance coverage, play a crucial role in facilitating patient access to atherectomy procedures by offsetting treatment costs. This favorable reimbursement environment encourages healthcare providers to adopt atherectomy devices and perform interventional procedures, driving market demand and growth.
As advancements in healthcare reimbursement policies, including expanded coverage for minimally invasive procedures and innovative medical technologies, further bolster market prospects for coronary atherectomy devices. Healthcare payers recognize the clinical benefits of atherectomy procedures in treating coronary artery disease (CAD), such as improved patient outcomes and reduced hospitalization rates, leading to increased reimbursement support. As a result, medical device manufacturers are incentivized to invest in research and development to innovate and improve atherectomy technologies, meeting the evolving needs of healthcare providers and patients. Overall, the favorable reimbursement scenario acts as a significant catalyst for market expansion and innovation in the global coronary atherectomy devices market.
Restraints :
- Stringent Regulatory Framework
- High Cost of Procedures
-
Limited Availability of Trained Specialists - The Global Coronary Atherectomy Devices Market is facing challenges due to the limited availability of trained specialists proficient in performing atherectomy procedures. Atherectomy techniques require specialized skills and expertise to ensure safe and effective plaque removal while minimizing the risk of complications. However, the training and education required to master these techniques are often limited, leading to a shortage of qualified interventional cardiologists and healthcare professionals capable of performing atherectomy procedures.
The scarcity of trained specialists poses a significant barrier to the widespread adoption of atherectomy devices, particularly in regions with limited access to advanced cardiovascular care. As a result, patients in these areas may face challenges in accessing optimal treatment options for coronary artery disease (CAD) and related conditions. Addressing this issue requires concerted efforts from healthcare organizations, medical device manufacturers, and educational institutions to expand training programs and enhance skill development opportunities for healthcare professionals. By investing in training initiatives and promoting knowledge sharing, stakeholders can help alleviate the shortage of trained specialists and improve patient access to atherectomy procedures, ultimately driving market growth and advancing cardiovascular care globally.
Opportunities :
- Development of New Technologies
-
Focus on Minimally Invasive Procedures - The Global Coronary Atherectomy Devices Market is increasingly focusing on minimally invasive procedures to address coronary artery disease (CAD) with greater precision and reduced patient discomfort. Atherectomy procedures offer a less invasive alternative to traditional open-heart surgeries, allowing for plaque removal from coronary arteries while minimizing trauma to surrounding tissues. This shift towards minimally invasive techniques is driven by several factors, including advancements in technology, improved patient outcomes, and a growing preference for less invasive treatment options among patients and healthcare providers alike.
The adoption of minimally invasive atherectomy procedures is supported by a growing body of clinical evidence demonstrating their efficacy and safety in CAD management. These procedures often result in shorter recovery times, reduced hospital stays, and lower rates of complications compared to traditional surgical interventions. As a result, the Global Coronary Atherectomy Devices Market is witnessing increased demand for devices that enable minimally invasive approaches, driving innovation and market growth in this segment. This focus on minimally invasive procedures underscores the market's commitment to enhancing patient care and improving treatment outcomes in the management of coronary artery disease.
Competitive Landscape Analysis
Key players in Global Coronary Atherectomy Devices Market include;
- Boston Scientific
- Philips
- Cardiovascular Systems
- Spectranetics
- Medtronic
In this report, the profile of each market player provides following information:
- Company Overview and Product Portfolio
- Key Developments
- Financial Overview
- Strategies
- Company SWOT Analysis
- Introduction
- Research Objectives and Assumptions
- Research Methodology
- Abbreviations
- Market Definition & Study Scope
- Executive Summary
- Market Snapshot, By Product
- Market Snapshot, By Application
- Market Snapshot, By End User
- Market Snapshot, By Region
- Global Coronary Atherectomy Devices Market Dynamics
- Drivers, Restraints and Opportunities
- Drivers
- Rising Prevalence of Cardiovascular Diseases (CVDs)
- Technological Advancements
- Favorable Reimbursement Scenario
- Restraints
- Stringent Regulatory Framework
- High Cost of Procedures
- Limited Availability of Trained Specialists
- Opportunities
- Development of New Technologies
- Focus on Minimally Invasive Procedures
- Drivers
- PEST Analysis
- Political Analysis
- Economic Analysis
- Social Analysis
- Technological Analysis
- Porter's Analysis
- Bargaining Power of Suppliers
- Bargaining Power of Buyers
- Threat of Substitutes
- Threat of New Entrants
-
Competitive Rivalry
- Drivers, Restraints and Opportunities
- Market Segmentation
- Global Coronary Atherectomy Devices Market, By Product, 2021 - 2031 (USD Million)
- Directional Atherectomy Devices
- Orbital Atherectomy Devices
- Photo-Ablative Atherectomy Devices
- Rotational Atherectomy Devices
- Others
- Global Coronary Atherectomy Devices Market, By Applicaton, 2021 - 2031 (USD Million)
- Peripheral Vascular
- Cardiovascular
- Neurovascular
- Global Coronary Atherectomy Devices Market, By End User, 2021 - 2031 (USD Million)
- Hospitals And Surgical Centers
- Ambulatory Care Centers
- Research Laboratories And Academic Institutes.
- Global Coronary Atherectomy Devices Market, By Geography, 2021- 2031 (USD Million)
- North America
- United States
- Canada
- Europe
- Germany
- United Kingdom
- France
- Italy
- Spain
- Nordic
- Benelux
- Rest of Europe
- Asia Pacific
- Japan
- China
- India
- Australia & New Zealand
- South Korea
- ASEAN (Association of South East Asian Countries)
- Rest of Asia Pacific
- Middle East & Africa
- GCC
- Israel
- South Africa
- Rest of Middle East & Africa
- Latin America
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- North America
- Global Coronary Atherectomy Devices Market, By Product, 2021 - 2031 (USD Million)
- Competitive Landscape
- Company Profiles
- Boston Scientific
- Philips
- Cardiovascular Systems
- Spectranetics
- Medtronic
- Company Profiles
- Analyst Views
- Future Outlook of the Market